Expanding on the traditional triple-taper design, Zimmer Biomet has launched the Z1™ Femoral Hip System, a design that ...

Stratos Wealth Partners LTD. lessened its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 2.5% during the ...

leveraging the Z1's versatility and ease of installation. Zimmer Biomet also recently received US regulatory approval of its Oxford partial cementless knee. While Oxford has been a dominant ...

Barclays lowered the firm’s price target on Zimmer Biomet (ZBH) to $112 from $118 and keeps an Underweight rating on the shares. The firm ...

Q4 2024 Earnings Call Transcript February 6, 2025 Zimmer Biomet Holdings, Inc. beats earnings expectations. Reported EPS is ...

Truist analyst Richard Newitter lowered the firm’s price target on Zimmer Biomet (ZBH) to $113 from $118 and keeps a Hold rating on the shares.

Zimmer Biomet Holdings, Inc. ZBH is scheduled to report fourth-quarter 2024 results on Feb. 6, before market open. See the ...

Zimmer Biomet provided 2025 guidance of constant currency ... Hips grew 4%, bolstered by the initial rollout of the Z1 Triple Tapered Stem. Adjusted gross margin was reported at 71.3%, while ...

Zimmer Biomet to acquire Paragon 28 for $13/share, totaling $1.2B in enterprise value. Deal expected to close in H1 2025, with potential $1/share CVR based on 2026 sales milestones. Brand New ...

Please go ahead. Thank you, Operator, and good morning, everyone. Welcome to Zimmer Biomet Biomet's fourth quarter 2024 earnings conference call. Joining me on today's call are Iwan Tornos ...